Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SIMC1 pseudogene 1 (SIMC1P1) is a human pseudogene related in sequence to the SUMO Interacting Motifs Containing 1 (SIMC1) gene. Pseudogenes are stretches of DNA that share similarity with known protein-coding genes but generally lack the ability to code for functional proteins due to disabling mutations and loss of regulatory elements. Most pseudogenes, including SIMC1P1, are considered nonfunctional genomic elements, although some pseudogenes elsewhere in the genome are reported to play regulatory roles at the RNA level, such as acting as competing endogenous RNAs or miRNA sponges. However, there is no direct evidence that SIMC1P1 itself carries out such regulatory or pathological roles, nor is it a drug target or disease biomarker[5][2][3][9]. In summary, SIMC1P1 is not a recognized therapeutic target and should not be considered as such in structured molecular target databases. It is best classified simply as a pseudogene, with no established biological, clinical, or pharmacological significance based on current data.
None; no drugs target pseudogenes directly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SIMC1 pseudogene 1 (SIMC1P1).